PECULIARITIES OF PSYCHOCORRECTION AND PSYCHOPROPHYLACTICS OF MAIN FORMS IN ANXIETY DISORDERS
- Authors: Yaltonsky V.M1, Atamanov A.A2
-
Affiliations:
- Moscow state medical and stomatologic university
- South-Ural state medical university
- Issue: Vol XLV, No 3 (2013)
- Pages: 33-38
- Section: Articles
- URL: https://bakhtiniada.ru/1027-4898/article/view/13787
- DOI: https://doi.org/10.17816/nb13787
- ID: 13787
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Vladimir M Yaltonsky
Moscow state medical and stomatologic university
Email: yaltonsky@mail.ru
127473,Моscow,Delegatsky street, 20, building.1
Aleksei A Atamanov
South-Ural state medical university
Email: atamanov_psy@mail.ru
454091, Chelyabinsk,Vorovsky street, 64
References
- Менделевич В.Д. О некоторых психологических механизмах неврозогенеза // Психологический журнал. 1990. №6. С.113‒117
- Менделевич В.Д. Расстройства зависимого поведения (к постановке проблемы) // Российский психиатрический журнал. 2003. №1. С. 5‒9
- Старшенбаум А.В. Суицидология и кризисная психотерапия. М.: Когито-центр, 2005. 376 с
- Цыганков Д.Б., Малыгин В.Л., Агасарян Э.Г., Цыганков Б.Д. Психологические защиты у больных алкоголизмом и паническим расстройством // Журнал неврологии и психиатрии им. С.С. Корсакова. 2008. Т. 108, №11. С. 96–97
- Boden J.M., Fergusson D.M., Horwood L.J. Anxiety disorders and suicidal behaviors in adolescence and young adulthood: findings from a longitudinal study // Psychol. Med. 2007. Vol. 37. P. 431–440
- Davidson J.R., Wittchen H.U., Llorca P.M. et al. Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: a double-blind placebo controlled trial // Eur. Neuropsychopharmacol. 2008. Vol. 18. P. 673–681
- Grant B.F., Hasin D.S., Stinson F.S. et al. Prevalence, correlates, comorbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the national epidemiologic survey on alcohol and related conditions // Psychol. Med. 2005. Vol. 35. P. 747–759
- Kessler R.C., Berglund P., Demler O. et al. Lifetime prevalence and age of onset distributions of DSM-IV disorders in the national comorbidity survey replication // Arch. Gen. Psychiatry. 2005. Vol. 62. P. 593–602
- Lorenz R.A., Jackson C.W., Saitz M. Adjunctive Use of Atypical Antipsychotics for Treatment-resistant Generalized Anxiety Disorder // Pharmacotherapy. 2010. Vol. 30(9). P. 942‒951
- Menza M.A., Dobkin R.D., Marin H. An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder // J. Clin. Psychopharmacol. 2007. Vol. 27. P. 207–210
- Wittchen H.U. Generalized anxiety disorder: prevalence, burden, and cost to society // Depress Anxiety 2002. Vol. 16. P. 162–171
Supplementary files
